Literature DB >> 20947351

Inhibitors selective for HDAC6 in enzymes and cells.

Praveer K Gupta1, Robert C Reid, Ligong Liu, Andrew J Lucke, Steve A Broomfield, Melanie R Andrews, Matthew J Sweet, David P Fairlie.   

Abstract

Histone deacetylase inhibitors with anticancer or anti-inflammatory activity bind to Class I or Class I and II HDAC enzymes. Here we compare selectivity of inhibitors of a Class II HDAC enzyme (HDAC6) and find one that retains high selectivity in macrophages.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947351     DOI: 10.1016/j.bmcl.2010.09.100

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.

Authors:  Zhixuan Loh; Rebecca L Fitzsimmons; Robert C Reid; Divya Ramnath; Andrew Clouston; Praveer K Gupta; Katharine M Irvine; Elizabeth E Powell; Kate Schroder; Jennifer L Stow; Matthew J Sweet; David P Fairlie; Abishek Iyer
Journal:  Br J Pharmacol       Date:  2019-08-17       Impact factor: 8.739

2.  Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.

Authors:  Priya Poonia; Monika Sharma; Prakash Jha; Madhu Chopra
Journal:  Mol Divers       Date:  2022-10-10       Impact factor: 3.364

Review 3.  Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.

Authors:  Melissa D Cantley; David R Haynes
Journal:  Inflammopharmacology       Date:  2013-01-23       Impact factor: 4.473

4.  Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays.

Authors:  Zainab Noor; Noreen Afzal; Sajid Rashid
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

5.  Insecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprina.

Authors:  Neil H Bagnall; Barney M Hines; Andrew J Lucke; Praveer K Gupta; Robert C Reid; David P Fairlie; Andrew C Kotze
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-01-10       Impact factor: 4.077

6.  Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity.

Authors:  Xiaoyang Li; Elizabeth S Inks; Xiaoguang Li; Jinning Hou; C James Chou; Jian Zhang; Yuqi Jiang; Yingjie Zhang; Wenfang Xu
Journal:  J Med Chem       Date:  2014-04-15       Impact factor: 7.446

7.  Pharmacoinformatic Investigation of Medicinal Plants from East Africa.

Authors:  Conrad V Simoben; Ammar Qaseem; Aurélien F A Moumbock; Kiran K Telukunta; Stefan Günther; Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Mol Inform       Date:  2020-10-08       Impact factor: 3.353

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.